Brief: Alpha Cognition Announces Positive Data From Pre-Clinical Studies And Discovery Of Gem Combinations With Potential For Neurodegenerative Disease Treatment
13/06/2022 14:31
June 13 (Reuters) - Alpha Cognition Inc ACOG.V :
* ALPHA COGNITION ANNOUNCES POSITIVE DATA FROM PRE-CLINICAL
STUDIES AND DISCOVERY OF GEM COMBINATIONS WITH POTENTIAL FOR
NEURODEGENERATIVE DISEASE TREATMENT
Source text for Eikon: ID:nBw9kCHvha
Further company coverage: ACOG.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Cognition
See all newsBrief: Alpha Cognition Announces Pricing Of $50 Million Upsized Public Offering And Nasdaq Listing
Brief: Alpha Cognition Inc - Files Registration Statement For $25 Million Offering
Brief: Alpha Cognition Announces Completion Of $4.545 Million Convertible Note And Warrants Bridge Financing
Brief: Alpha Cognition Says On Track To Secure Financing For Continued Growth
Brief: Alpha Cognition Inc Says Applied To List Common Shares On Nasdaq Under Trading Symbol “Acog”